Correlation Between Vincerx Pharma, and BridgeBio Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma, and BridgeBio Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma, and BridgeBio Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma, Common and BridgeBio Pharma, you can compare the effects of market volatilities on Vincerx Pharma, and BridgeBio Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma, with a short position of BridgeBio Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma, and BridgeBio Pharma.

Diversification Opportunities for Vincerx Pharma, and BridgeBio Pharma

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vincerx and BridgeBio is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma, Common and BridgeBio Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BridgeBio Pharma and Vincerx Pharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma, Common are associated (or correlated) with BridgeBio Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BridgeBio Pharma has no effect on the direction of Vincerx Pharma, i.e., Vincerx Pharma, and BridgeBio Pharma go up and down completely randomly.

Pair Corralation between Vincerx Pharma, and BridgeBio Pharma

Given the investment horizon of 90 days Vincerx Pharma, is expected to generate 10.43 times less return on investment than BridgeBio Pharma. In addition to that, Vincerx Pharma, is 6.75 times more volatile than BridgeBio Pharma. It trades about 0.0 of its total potential returns per unit of risk. BridgeBio Pharma is currently generating about 0.2 per unit of volatility. If you would invest  4,887  in BridgeBio Pharma on August 26, 2025 and sell it today you would earn a total of  2,212  from holding BridgeBio Pharma or generate 45.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy95.31%
ValuesDaily Returns

Vincerx Pharma, Common  vs.  BridgeBio Pharma

 Performance 
       Timeline  
Vincerx Pharma, Common 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Vincerx Pharma, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Vincerx Pharma, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
BridgeBio Pharma 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in BridgeBio Pharma are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile forward indicators, BridgeBio Pharma displayed solid returns over the last few months and may actually be approaching a breakup point.

Vincerx Pharma, and BridgeBio Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vincerx Pharma, and BridgeBio Pharma

The main advantage of trading using opposite Vincerx Pharma, and BridgeBio Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma, position performs unexpectedly, BridgeBio Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BridgeBio Pharma will offset losses from the drop in BridgeBio Pharma's long position.
The idea behind Vincerx Pharma, Common and BridgeBio Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world